Invitrogen™ Equine VEGF-A ELISA Kit

Ref.: BL-RE-090896Manufacturer ref.: EE9RBX10 10 x 96 tests
€4,995.00 excl. VAT

Equine VEGF-A quantitates equine VEGF-A in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant equine VEGF-A.

Accession number
facteur angiogénique ; ETID309976.16 ; eVEGF120 ; eVEGF164 ; homologue VEGF121 humain ; MGC70609 ; MVCD1 ; facteur de croissance endothéliale vasculaire ovin ; RP1-261G23.1 ; produit protéique sans nom ; VAS ; facteur de croissance endothéliale vasculaire ; précurseur du facteur de croissance endothéliale vasculaire (VEGF) ; isoforme du facteur de croissance endothéliale vasculaire 121 ; facteur de croissance endothéliale vasculaire 164 ; facteur de croissance endothéliale vasculaire 165 b ; isoforme du facteur de croissance endothéliale vasculaire 182 ; facteur de croissance endothéliale vasculaire 188 ; facteur de croissance 188 ; isoforme du facteur de croissance endothéliale vasculaire 188 ; facteur de croissance endothéliale vasculaire 189 ; facteur de croissance endothéliale vasculaire A ; facteur de croissance endothéliale vasculaire A121 ; facteur de croissance endothéliale vasculaire A165 ; facteur de croissance endothéliale vasculaire
Dose range
4 to 1000 pg/ml
Sensitivity of the dosage
4 pg/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen

Equine VEGF-A quantitates equine VEGF-A in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant equine VEGF-A.

Equine VEGF-A quantitates equine VEGF-A in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant equine VEGF-A.

VEGF (vascular endothelial growth factor), which is a homodimer glycoprotein bound to disulfide involved in 45 kDa angiogenesis, promotes tumour progression and metastases. VEGF has various effects on vascular endothelium, including the ability to promote endothelial cell viability, mitogenesis, chemotaxia and vascular permeability. VEGF's family currently includes VEGF-A, VEGF-B, VEGF-C, VEGF-D, VEGF-E and PIGF. The VEGF and its receptor system have proven to be the fundamental regulators of cell signaling of langenogenicity. Most tumours have the absolute requirement of angiogenesis and VEGF has been described as the most potent angiogenic cytokine associated with this process. To date, 5 different VEGF isoforms have been described. These isoforms are generated following an alternative splicing from a single VEGF gene. These various isoforms have been shown to bind to two tyrosine kinase flt-1 receptors (VEGFR-1) and flk-1/KDR (VEGFR-2 receptors), which have been expressed almost exclusively on endothelial cells. VEGF and its high affinity binding receptors, tyrosines kinases FLK1 and FLT1, are considered important for the development of embryonic vasculature. Studies have shown that an alternately spliced form of FLT1 produces a soluble protein, called sFLT1, which binds vascular endothelial growth factor with high affinity, acting as an inhibitor in angiogenesis. High levels of VEGF are associated with POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammapathy, skin changes), also known as Crow-Fukase syndrome, which affects several organs of the body.

Sensitivity

Sensitivity of the dosage: 4 pg/ml.

Measurement range

Dose range: 4 to 1,000 pg/ml.

Duration of dosing

Total duration of dosing: 4 h 45 min.

Reproducibility

Coefficient of intradose variation < 10%, interdose < 12%.

Samples

Sample type: Plasma, Serum, Surnatant (Serum volume, 50 μl; Plasma, 50 μl; Supernatant, 50 μl).

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)17884050
Specifications
Accession numberangiogenic factor; ETID309976.16; eVEGF120; eVEGF164; homologue VEGF121 human; MGC70609; MVCD1; ovine vascular endothelial growth factor; RP1-261G23.1; nameless protein product; VAS; vascular endothelial growth factor; precursor of endoth growth factor
Dose range4 to 1000 pg/ml
Sensitivity of the dosage4 pg/ml
ConjugateBiotin
Product typeELISA
Type of samplePlasma, Serum, Surnatant
For use with (equipment)Colorimetric microplate reader
Genetic identification (Enter)Q9GKR0
Gene symbol(s)VEGFA analysis
Coefficient of inter-dose variation< 12%
Coefficient of intra-dose variation< 10%
Contents of kits96-well pre-coated plate, standard, dosing diluent concentrate, biotinylated detection antibody, SAV-HRP, washing pad, chromogen, stop solution, adhesive plate lids
Marker or dyeHRP
Quantity10 x 96 tests
Regulatory statusUse exclusively for research
TargetVEGF analysis
Test time1 h 20 min
Physical characteristics
Volume of sampleSerum, 50 μl; Plasma, 50 μl; Supernatant, 50 μl
Storage and shipping
Storage conditions2°C to 8°C
Total duration of dosing4 h 45 min

Origin and customs

Manufacturer ref.EE9RBX10
Country of originUnited States
HS customs code3002 12 00 00
A question or a specific configuration?
Contact us for a quote.